Article
Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy.
The American journal of surgical pathology - 1 Apr 2013
Maeshima Akiko M, Taniguchi Hirokazu, Fukuhara Suguru, Morikawa Noriyuki, Munakata Wataru, Maruyama Dai, Kim Sung-Won, Watanabe Takashi, Kobayashi Yukio, Tobinai Kensei, Tsuda Hitoshi
Abstract excerpt
Recently, a CD20-negative phenotypic change in CD20-positive B-cell non-Hodgkin lymphoma (B-NHL) after rituximab therapy was described. We report the follow-up data of 10 B-NHL patients showing this change after rituximab therapy. Ten patients (4 men and 6 women; median age, 57 y) with B-NHL who were initially CD20 positive and became CD20 negative after rituximab therapy were analyzed. Clinicopathologic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.